Tuesday 17 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Financing

Hydrofarm posts Q3 2026 sales drop to $14.5M and wipes out $109M term loan in October recapitalization

Hydrofarm, a controlled environment agriculture supplier that is not a pharma company, reported Q3 2026 results (quarter ended Sept 30) on Nov 16, 2026. Net sales fell about 51% to $14.5M, while net loss narrowed to $7.8M and gross margin improved. In October the company recapitalized, converting its $109M Term Loan into preferred stock and warrants for lenders and raising about $8.3M in a registered direct offering and private placement, after selling Aurora Peat Products for $16M.

16 Nov 2026 · Hydrofarm Holdings Group, Inc. HYFM · Company news

Company's press release (SEC filing): Hydrofarm Holdings Group, Inc. ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More FinancingAll →